AI assistant
Sending…
TREACE MEDICAL CONCEPTS, INC. — Director's Dealing 2026
Jan 14, 2026
32908_dirs_2026-01-13_c30215a2-34c2-4971-ab4b-8493dd68872a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK: 0001630627
Period of Report: 2026-01-10
Reporting Person: Hair Mark (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-01-10 | Common Stock | F | 8719 | — | Disposed | 510245 | Direct |
Footnotes
F1: Includes 398,009 restricted stock units.
More from TREACE MEDICAL CONCEPTS, INC.
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 9
Annual Report
2026
Apr 6
Proxy Solicitation & Information Statement
2026
Apr 6
Annual Report
2026
Feb 27
Regulatory Filings
2026
Feb 27
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12